Picture of Nextplat logo

NXPL — Nextplat News Story

0.000.00%
us flag iconLast trade - 00:00
TelecomsSpeculativeMicro CapTurnaround

NextPlat Q2 revenue rises on E-commerce demand

NextPlat Q2 revenue rises on E-commerce demand 


Overview

  • US healthcare and technology provider's Q2 revenue grew 21% sequentially, driven by contracted pharmacy and e-commerce

  • Net loss for Q2 fell 87% yr/yr to $144,000, with gross margin reaching a record 40%

  • Company attributes improved results to higher-margin 340B pharmacy services and strong e-commerce demand


Outlook

  • Company expects higher-margin 340B contracted services revenue to increase in coming quarters

  • NextPlat anticipates sustainable positive operating income for the remainder of 2026

  • Company expects new customer contracts to increase revenue in Q3, with more impact in early Q4


Result Drivers

  • 340B CONTRACTED PHARMACY GROWTH - Co said higher-margin 340B contracted pharmacy services prescription volumes grew over 33% yr/yr, supported by new client signings and business development

  • E-COMMERCE DEMAND - Sequential e-commerce revenue rose 27%, driven by global demand for satellite-based IoT and Push-to-Talk hardware, especially from government and military customers

  • GROSS MARGIN IMPROVEMENT - Healthcare segment gross margin rose to 46%, attributed to new contracted medication fulfillment services and lower drug acquisition costs from Medicare Drug Price Negotiation Program


Company press release: ID:nPnbr3RPxa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$11.88 mln

$11 mln (1 Analyst)

Q2 Loss Per Share

$0.05


Analyst Coverage

  • The one available analyst rating on the shares is "buy"

  • The average consensus recommendation for the wireless telecommunications services peer group is "buy"

  • Wall Street's median 12-month price target for NextPlat Corp is $12.00, about 78.8% above its August 12 closing price of $6.71


Reuters Recommended Reads

  • Aug 11 - Cardinal Health forecasts full-year profit above estimates on specialty drug strength

  • Aug 12 - SKYX Q2 revenue beats estimates on e-commerce, retail expansion

  • Aug 11 - Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Nextplat

See all news